Wegovy Constipation Facts 24% Clinical Trial Rate According to FDA prescribing information, constipation is the 4th most common side effect after nausea (44%), diarrhea (30%), and vomiting (24%)
If you are currently on semaglutide and experiencing heartburn, there is no need to worry
Reactions tend to be localized to application areas
GLP-1 drugs, which include medications used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have greatly increased in popularity in recent years due to their demonstrated effectiveness
Weight Loss & Metabolic Health | Boost Your Metabolism, Transform Your Body What Is Weight Loss & Metabolic Health Treatment
Wegovy is the brand name for semaglutide, a GLP-1 medication for weight loss that is very similar to Mounjaro and is currently licensed in the UK